IR and IGF-1R can activate both the MAP kinase pathway and the PI 3-kinase pathway, yet in the CRC cells, inhibition of IR and IGF-1R primarily blocked Akt activation, and reduced Akt function. Here, IGF1R is linked to colorectal carcinoma.